Filter
521
Text search:
stressors
Featured
47
73
Language
Document type
266
133
45
35
22
11
3
2
2
1
1
Countries / Regions
27
14
12
9
8
8
7
7
7
6
6
5
5
5
5
5
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
111
24
20
16
14
13
Toolboxes
204
65
51
28
23
22
20
18
9
7
6
5
4
3
3
3
2
2
1
1
1
1
1
Introduction
Chapter A.3
Introduction
Chapter A.4
2017 edition
Introduction
Chapter A.9
Introduction
Chapter A.10
Introduction
Chapter A.14
Externalising disorders
Chapter D.2
Mood disorders
Chapter E.1
2015 edition
Mood disorders
Chapter E.2
Mood disorders
Chapter E.3
2016 edition
Mood disorders
Chapter E.4
2018 edition
Anxiety disorders
Chapter F.2
Psychatry & Pediatrics
Chapter I.3
Miscellaneous
Child and adolescent psychiatric emergencies
Chapter J.1
Miscellaneous
Chapter J.8
Published: February 23, 2010
https://doi.org/10.1371/journal.pmed.1000235
Volume 7 | Issue 2 | e1000235
(2015)
Scoping question: Are antidepressants (specifically, tricyclic antidepressants and selective serotonin reuptake inhibitors) effective and safe in adolescents with moderate-severe depressive disorder for whom psychosocial interventions have proven ineffective?
Q10: Are antidepressants (Tricyclic antidepressants (TCA), Selective serotonin reuptake inhibitors (SSRIs)) effective and safe in children 6-12 years of age with depressive episode/disorder?
